眼科 ›› 2026, Vol. 35 ›› Issue (2): 97-102.doi: 10.13281/j.cnki.issn.1004-4469.2026.02.003

• 论著 • 上一篇    下一篇

不同晶状体联合手术治疗真性小眼球继发青光眼的效果分析

金曼曼1  高凤 王嘉健 孔祥梅2   

  1. 1江苏省人民医院宿迁医院眼科,江苏宿迁223800; 2复旦大学附属眼耳鼻喉科医院眼科,上海 200031
  • 收稿日期:2025-06-07 出版日期:2026-03-25 发布日期:2026-03-25
  • 通讯作者: 孔祥梅,Email:kongxm95@163.com

Analysis of the efficacy of different lens combination surgeries for the treatment of secondary glaucoma in nanophthalmos

Jin Manman1, Gao Feng2, Wang Jiajian2, Kong Xiangmei2   

  1. 1 Department of Ophthalmology, Jiangsu Province(Suqian) Hosipital, Suqian Jiangsu 223800, China; 2 Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai 200031, China
  • Received:2025-06-07 Online:2026-03-25 Published:2026-03-25
  • Contact: Kong Xiangmei, Email:kongxm95@163.com

摘要:  目的  研究分析不同晶状体联合手术治疗真性小眼球继发青光眼的疗效及并发症。设计  回顾性病例系列。研究对象  2015年10月至2023年11月在复旦大学附属眼耳鼻喉科医院行晶状体联合手术治疗的真性小眼球(眼轴≤20.5 mm)继发闭角型青光眼的患者68例(68眼)。方法  根据手术方式将患者分为三组:超声乳化+房角分离(A组) 18眼、超声乳化+房角分离+巩膜切除(B组)12眼、超声乳化+房角分离+巩膜切除+前部玻璃体切除(C组)38眼。所有患者术后随访时间均超过半年。眼压完全控制定义为术后不用降眼压药下眼压≤21 mmHg。恶性青光眼、脉络膜脱离、脉络膜上腔出血、视网膜脱离被认为是严重并发症。主要指标  眼压完全控制率、视力未下降率、严重并发症发生率、再次手术率。结果  术后末次随访A组、B组、C组眼压完全控制率分别为50.0%(9眼)、83.3%(10眼)、81.6%(31眼);视力未下降率分别为77.8%(14眼)、66.7%(8眼)、52.6%(20眼);严重并发症发生率分别为22.3%(4眼)、16.7%(2眼)、13.2%(5眼);再次手术率分别为27.8%(5眼)、16.7%(2眼)、5.3%(2眼)。C组相对于A组,眼压控制效果更佳(P=0.025),再次手术率更低(P=0.029),视力下降眼数稍多,但未见显著差异(P=0.087);B组相对于A组,眼压控制率稍高(P=0.121),再次手术率稍低(P=0.669),但均无统计学差异,视力下降眼数较少,视功能维持更好(P=0.678)。严重并发症发生率A组最高,其次是B组、C组,但未见统计学显著差异。结论  超声乳化+房角分离+巩膜切除+前部玻璃体切除术式单次手术眼压控制较好,严重并发症较低,适合以眼压控制和减少再手术为第一目标的极高危眼。超声乳化+房角分离+巩膜切除术式术后视功能维持更好,更适合视功能储备尚可但解剖风险较高的患者。两者均为治疗真性小眼球继发青光眼较好的术式选择。

关键词: 真性小眼球, 继发性青光眼, 晶状体联合手术

Abstract:  Objective  To investigate the efficacy and complications of different combined lens surgeries for secondary glaucoma in nanophthalmos. Design Retrospective case series. Participants Sixty-eight patients (68 eyes) suffered from secondary angle-closure glaucoma with nanophthalmos (axial length ≤20.5 mm) who underwent combined lens surgery at Fudan University Eye and ENT Hospital between October 2015 and November 2023. Methods Patients were divided into three groups according to surgical approach: Group A (phacoemulsification combined with goniosynechialysis, 18 eyes), Group B (phacoemulsification combined with goniosynechialysis and sclerectomy, 12 eyes), and Group C (phacoemulsification combined with goniosynechialysis, sclerectomy, and anterior vitrectomy, 38 eyes). All patients were followed up for more than 6 months postoperatively. Complete intraocular pressure (IOP) control was defined as IOP ≤21 mmHg without antiglaucoma medications. Malignant glaucoma, choroidal detachment, suprachoroidal hemorrhage, and retinal detachment were considered severe complications. Main Outcome Measures  Complete IOP control rate, visual acuity maintenance rate, incidence of severe complications, and reoperation rate. Results  At the final follow-up, in Group A, Group B, Group C, the complete IOP control rates were 50.0% (9 eyes), 83.3% (10 eyes), and 81.6% (31 eyes) respectively; the visual acuity maintenance rates were 77.8% (14 eyes), 66.7% (8 eyes), and 52.6% (20 eyes), respectively; the incidences of severe complications were 22.3% (4 eyes), 16.7% (2 eyes), and 13.2% (5 eyes), respectively; the reoperation rates were 27.8% (5 eyes), 16.7% (2 eyes), and 5.3% (2 eyes), respectively. Compared with Group A, Group C demonstrated significantly better IOP control (P=0.025) and lower reoperation rate (P=0.029), although the difference in visual acuity decline was not statistically significant (P=0.087). Compared with Group A, Group B showed higher IOP control rate (P=0.121) and lower reoperation rate (P=0.669), but neither reached statistical significance; however, visual function was better preserved in Group B (P=0.678). The incidence of severe complications was highest in Group A, followed by Group B and Group C, though no statistically significant differences were observed among the groups. Conclusions The surgical approach combining phacoemulsification, goniosynechialysis, sclerectomy, and anterior vitrectomy provides favorable single-surgery IOP control with relatively low complication rates, making it suitable for extremely high-risk eyes prioritizing IOP control and reduction of reoperations. The approach combining phacoemulsification, goniosynechialysis, and sclerectomy offers better preservation of visual function and is more appropriate for patients with acceptable visual reserve but high anatomical risk. Both represent viable surgical options for secondary glaucoma in nanophthalmos..

Key words: Nanophthalmos, Secondary glaucoma, Combined lens surgeries